DE60027575D1 - Verwendung von Spinosad oder einer Zusammensetzung enthaltend spinosad - Google Patents

Verwendung von Spinosad oder einer Zusammensetzung enthaltend spinosad

Info

Publication number
DE60027575D1
DE60027575D1 DE60027575T DE60027575T DE60027575D1 DE 60027575 D1 DE60027575 D1 DE 60027575D1 DE 60027575 T DE60027575 T DE 60027575T DE 60027575 T DE60027575 T DE 60027575T DE 60027575 D1 DE60027575 D1 DE 60027575D1
Authority
DE
Germany
Prior art keywords
spinosad
formulations
composition containing
controlling
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60027575T
Other languages
English (en)
Other versions
DE60027575T2 (de
Inventor
Earl Snyder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22526570&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60027575(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE60027575D1 publication Critical patent/DE60027575D1/de
Application granted granted Critical
Publication of DE60027575T2 publication Critical patent/DE60027575T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/22—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom rings with more than six members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Dentistry (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Environmental Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
DE60027575T 1999-08-12 2000-08-02 Verwendung von Spinosad oder einer Zusammensetzung enthaltend spinosad Expired - Lifetime DE60027575T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14861899P 1999-08-12 1999-08-12
US148618P 1999-08-12
PCT/US2000/019557 WO2001011963A1 (en) 1999-08-12 2000-08-02 Oral treatment of companion animals with ectoparasiticidal spinosyns

Publications (2)

Publication Number Publication Date
DE60027575D1 true DE60027575D1 (de) 2006-06-01
DE60027575T2 DE60027575T2 (de) 2007-02-15

Family

ID=22526570

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60027575T Expired - Lifetime DE60027575T2 (de) 1999-08-12 2000-08-02 Verwendung von Spinosad oder einer Zusammensetzung enthaltend spinosad
DE201112100022 Pending DE122011100022I1 (de) 1999-08-12 2000-08-02 Verwendung von Spinosad oder einer Zusammensetzungenthaltend spinosad.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE201112100022 Pending DE122011100022I1 (de) 1999-08-12 2000-08-02 Verwendung von Spinosad oder einer Zusammensetzungenthaltend spinosad.

Country Status (25)

Country Link
US (1) US6664237B1 (de)
EP (1) EP1207756B1 (de)
JP (2) JP5046455B2 (de)
KR (1) KR100706146B1 (de)
AT (1) ATE324039T1 (de)
AU (1) AU775488B2 (de)
BE (1) BE2011C013I2 (de)
BR (1) BR0013116B1 (de)
CA (1) CA2379329C (de)
CO (1) CO5410187A1 (de)
CY (1) CY1105000T1 (de)
DE (2) DE60027575T2 (de)
DK (1) DK1207756T3 (de)
ES (1) ES2261229T3 (de)
FR (1) FR11C0017I2 (de)
HU (1) HUP0202825A2 (de)
IL (2) IL147828A0 (de)
MX (1) MXPA02001505A (de)
MY (1) MY125485A (de)
NO (1) NO20020686L (de)
NZ (1) NZ516790A (de)
PT (1) PT1207756E (de)
TW (1) TWI244373B (de)
WO (1) WO2001011963A1 (de)
ZA (1) ZA200200565B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6933318B1 (en) 1999-08-12 2005-08-23 Eli Lilly And Company Topical organic ectoparasiticidal formulations
AUPQ441699A0 (en) 1999-12-02 2000-01-06 Eli Lilly And Company Pour-on formulations
DE10135550A1 (de) * 2001-07-20 2003-01-30 Bayer Cropscience Ag Verfahren zum Herstellen von neuen Spinosyn-Derivaten
HUP0500984A3 (en) 2001-09-17 2007-02-28 Lilly Co Eli Synergetic pesticidal formulations
DE602004017347D1 (de) * 2003-11-04 2008-12-04 Intervet Int Bv Azol-pestiziden
ES2526614T3 (es) 2004-03-05 2015-01-13 Nissan Chemical Industries, Ltd. Compuesto de benzamida sustituida con isoxazolina y agente de control de organismos nocivos
PL1744763T3 (pl) * 2004-04-29 2010-06-30 Elanco Us Inc Spinozyny do gojenia ran
SG159395A1 (en) * 2004-04-29 2010-03-30 Lilly Co Eli Use of spinosyns for wound healing
AU2006249441A1 (en) 2005-05-26 2006-11-30 Eli Lilly And Company Improved fish production
KR100855417B1 (ko) * 2006-10-27 2008-08-29 일라이 릴리 앤드 캄파니 스피노신을 포함하는 상처 치유용 제약 조성물
ES2666187T3 (es) 2007-06-27 2018-05-03 E. I. Du Pont De Nemours And Company Procedimiento de control de plagas en animales
US9820977B2 (en) 2008-10-03 2017-11-21 Bayer Healthcare Llc Systemic treatment of blood-sucking and blood-consuming parasites by oral administration of a parasiticidal agent
UA108200C2 (uk) * 2009-05-08 2015-04-10 Лікарські форми та способи застосування ектопаразитоцидів
AU2013273709B2 (en) * 2009-05-08 2015-04-23 Eli Lilly And Company Ectoparasiticidal methods and formulations
TWI510189B (zh) 2009-06-19 2015-12-01 Lilly Co Eli 殺外寄生蟲之方法及調配物
WO2010150100A1 (en) 2009-06-24 2010-12-29 Entarco Sa The use of spinosyns and spinosyn compositions against diseases caused by protozoans, viral infections and cancer
WO2011091122A1 (en) * 2010-01-25 2011-07-28 Eli Lilly And Company Methods for internally controlling or treating equine bot larvae
AU2011323082B2 (en) * 2010-11-05 2015-06-11 Eli Lilly And Company Methods for inhibiting insect infestations
ITMI20111945A1 (it) * 2011-10-26 2013-04-27 Zapi Ind Chimiche Spa Formulazione in forma idonea a veicolare un quantitativo dosato di una sostanza attiva
CN103125501A (zh) * 2011-11-30 2013-06-05 上海农乐生物制品股份有限公司 一种阿维菌素·多杀霉素水乳剂及其制备方法
AR091769A1 (es) * 2012-07-26 2015-02-25 Lilly Co Eli Formulaciones orales de dosis unica y metodos para el tratamiento de gatos con el ectoparasiticida espinosad
AU2013345149B2 (en) 2012-11-14 2016-10-27 Elanco Us Inc. Ectoparasiticidal methods and formulations
WO2020012406A1 (en) * 2018-07-11 2020-01-16 Jubilant Generics Limited Veterinary dosage forms
CN109221133A (zh) * 2018-09-28 2019-01-18 绩溪农华生物科技有限公司 一种多杀菌素增效水乳剂及其制备方法
EP4304722A1 (de) * 2021-03-11 2024-01-17 In the Bowl Animal Health, Inc. Verfahren zur bekämpfung von floh- und zeckenbefall bei einem säugetier
KR20230161995A (ko) * 2021-03-11 2023-11-28 인 더 보울 애니멀 헬스, 인크. 포유동물에서 진드기 감염을 제어하는 사료 및 방법
JP2024526193A (ja) * 2021-06-25 2024-07-17 イン ザ ボウル アニマル ヘルス，インコーポレーテッド 経口のネコ科動物の飼料およびネコ科動物におけるノミの侵入を制御する方法
WO2022271937A2 (en) * 2021-06-25 2022-12-29 In The Bowl Animal Health, Inc. Oral feline feed and methods for controlling flea infestations in a feline

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US576253A (en) * 1897-02-02 Manhole-cover
OA09249A (fr) 1988-12-19 1992-06-30 Lilly Co Eli Composés de macrolides.
US5362634A (en) 1989-10-30 1994-11-08 Dowelanco Process for producing A83543 compounds
JPH0375316A (ja) * 1989-08-18 1991-03-29 Tokyo Gas Denro Kk 熱処理炉
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5539089A (en) 1991-11-08 1996-07-23 Dowelanco A83543 aglycones and pseudoglycones
US5227295A (en) 1991-11-08 1993-07-13 Dowelanco Process for isolating A83543 and its components
US5202242A (en) 1991-11-08 1993-04-13 Dowelanco A83543 compounds and processes for production thereof
US5591606A (en) * 1992-11-06 1997-01-07 Dowelanco Process for the production of A83543 compounds with Saccharopolyspora spinosa
ATE150758T1 (de) 1993-03-12 1997-04-15 Dowelanco Neue a83543 verbindungen und verfahren zu ihrer herstellung
CN1130369C (zh) 1995-06-14 2003-12-10 道农业科学公司 对刺糖多孢菌素化合物的合成修饰
US5695776A (en) 1996-03-12 1997-12-09 Fmc Corporation Termite bait apparatus having grooves
US6001981A (en) * 1996-06-13 1999-12-14 Dow Agrosciences Llc Synthetic modification of Spinosyn compounds
GB9624501D0 (en) * 1996-11-26 1997-01-15 Zeneca Ltd Insecticial compositions and method
JPH11139912A (ja) * 1997-11-06 1999-05-25 Nissan Chem Ind Ltd 安定化される農薬組成物
ID27789A (id) * 1997-12-23 2001-04-26 Novartis Ag Penggunaan makrolida untuk mengendalikan hama
WO2000001347A2 (en) 1998-07-02 2000-01-13 Eli Lilly And Company Formulations for controlling human lice
WO2000060940A1 (en) 1999-04-12 2000-10-19 Dow Agrosciences Llc Aqueous dispersions of agricultural chemicals
EP1207851A1 (de) 1999-08-12 2002-05-29 Eli Lilly And Company Ektoparasitizide formulierungen zur topische anwendung
AU6605300A (en) 1999-08-12 2001-03-13 Eli Lilly And Company Control of ectoparasites using spinosyns
KR100731248B1 (ko) 1999-09-13 2007-06-25 다우 아그로사이언시즈 엘엘씨 살충제 마크롤라이드
AUPQ441699A0 (en) 1999-12-02 2000-01-06 Eli Lilly And Company Pour-on formulations

Also Published As

Publication number Publication date
NO20020686L (no) 2002-04-09
JP5427217B2 (ja) 2014-02-26
JP2012001563A (ja) 2012-01-05
JP2003506463A (ja) 2003-02-18
CA2379329C (en) 2009-10-20
JP5046455B2 (ja) 2012-10-10
TWI244373B (en) 2005-12-01
BR0013116A (pt) 2002-04-30
FR11C0017I1 (de) 2011-08-07
DE122011100022I1 (de) 2011-10-20
KR20020032550A (ko) 2002-05-03
CY1105000T1 (el) 2010-03-03
DK1207756T3 (da) 2006-08-14
IL147828A0 (en) 2002-08-14
FR11C0017I2 (fr) 2012-06-15
IL147828A (en) 2006-08-20
DE60027575T2 (de) 2007-02-15
PT1207756E (pt) 2006-07-31
AU775488B2 (en) 2004-08-05
MY125485A (en) 2006-08-30
BE2011C013I2 (de) 2019-10-16
CA2379329A1 (en) 2001-02-22
ZA200200565B (en) 2003-11-26
ES2261229T3 (es) 2006-11-16
EP1207756B1 (de) 2006-04-26
EP1207756A1 (de) 2002-05-29
US6664237B1 (en) 2003-12-16
NZ516790A (en) 2003-03-28
CO5410187A1 (es) 2004-06-30
BR0013116B1 (pt) 2013-01-22
AU6747600A (en) 2001-03-13
KR100706146B1 (ko) 2007-04-11
MXPA02001505A (es) 2002-07-02
WO2001011963A1 (en) 2001-02-22
NO20020686D0 (no) 2002-02-11
ATE324039T1 (de) 2006-05-15
HUP0202825A2 (en) 2003-03-28

Similar Documents

Publication Publication Date Title
ATE324039T1 (de) Verwendung von spinosad oder einer zusammensetzung enthaltend spinosad
BR0015188A (pt) Composições farmacêuticas
EA200401019A1 (ru) Дозированная лекарственная форма для перорального применения, содержащая ингибитор pde 4 в качестве действующего вещества и поливинилпирролидон в качестве вспомогательного вещества
EP2269613A3 (de) Feste orale Dosierungsform enthaltend eine Kombination von Glibenclamide und Metformine
ITRM920361A1 (it) Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo.
NO20011721D0 (no) N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor
TWI328576B (en) Diketohydrazine derivative compound, medicament containing same as active ingredient
RS50360B (sr) Farmaceutske formulacije derivata platine
CY1111698T1 (el) Συνδυασμος που περιλαμβανει εναν ανταγωνιστη υποδοχεα ατ1 και εναν ενισχυτη εκκρισης ινσουλινης ή εναν ευαισθητοποιητη ινσουλινης
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
DE59907481D1 (de) Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff
TW200509992A (en) Dosage form containing pantoprazole as active ingredient
PH27446A (en) Compound with gastric acid inhibitory effect
TW200503785A (en) Dosage form containing (S)-pantoprazole as active ingredient
DE60316714D1 (de) Pharmazeutische formulierung enthaltend olanzapin
CA2385755A1 (en) Prevention of colorectal cancer
PT1202956E (pt) Derivados terapeuticos e/ou nuricionalmente melhorados de ingredientes activos e composicoes de administracao oral contendo o mesmo
DK0469440T3 (da) Faste orale applikationsformer, der som aktivt stof indeholder ifosamid
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение
CA2409845A1 (en) Active substance combination containing a compound with an opioid effect and at least one further compound of formula i
DE60309926D1 (de) Steroid-verbindungen mit anti-tumoraler wirkung
SE9803277D0 (sv) Novel compounds
TH69069A (th) การรักษาแมลงรบกวนในสัตว์เลี้ยงโดยการให้ทางปาก
TH59050B (th) วิธีการใช้อีมาเมคตินในการรักษาปรสิตของปลา

Legal Events

Date Code Title Description
R067 Examining division decision granting supplementary protection certificate

Free format text: PRODUCT NAME: SPINOSAD ODER EIN SALZ HIERVON; REGISTRATION NO/DATE: EU/2/10/115/001-010 20110211

Spc suppl protection certif: 122011100022

Filing date: 20110715

Expiry date: 20200803

Extension date: 20250802

R069 Supplementary protection certificate granted

Free format text: PRODUCT NAME: SPINOSAD ODER EIN SALZ HIERVON; REGISTRATION NO/DATE: EU/2/10/115/001-010 20110211

Spc suppl protection certif: 122011100022

Filing date: 20110715

Expiry date: 20200803

Extension date: 20250802